Disease | Author (year) | Data collection period | Patients | n | All deaths | % | CVD Deaths | % Death rate | % CVD proportion of all deaths |
---|---|---|---|---|---|---|---|---|---|
CVD | Alwalkeel (2008) [30] | Jan 1989–Jan 2004 | T2DM adults | 1952 | 161 | 8.20% | 97 | 5.00% | 60.20% |
CVD | Cardoso (2008) [31] | 1994–96 to 2001 | T2DM adults | 471 | 121 | 25.70% | 44 | 9.30% | 36.40% |
CVD | Carnethon (2010) [32] | 1989–93 to 2005 | T2DM only | 659 | 468 | 71.00% | 211 | 32.0% | 45.10% |
CVD | Carnethon (2010) [32] | 1989–93 to 2005 | CVD only | 868 | 620 | 71.40% | 304 | 35.0% | 49.00% |
CVD | Carnethon (2010) [32] | 1989–93 to 2005 | T2DM + CVD | 260 | 219 | 84.20% | 129 | 49.60% | 58.90% |
CVD | Carnethon (2010) [32] | 1989–93 to 2005 | No T2DM or CVD | 3997 | 2095 | 52.40% | 710 | 17.8% | 33.90% |
CVD | Eeg-Olofsson (2010) [33] | 1997–98 to 2003 | T2DM adults | 18,334 | 1902 | 10.40% | 1456 | 7.90% | 76.60% |
CVD | Malik (2015) [34] | 2005–2011 | T2DM adults | 121,523 | 17,637 | 14.50% | 3722 | 3.10% | 21.10% |
CVD | Menzaghi (2014) [36] | 2001–2008 | GHS study—males | 242 | NR | – | 42 | 17.40% | – |
CVD | Menzaghi (2014) [36] | 2001–2008 | GHS study—females | 117 | NR | – | 16 | 13.70% | – |
CVD | Menzaghi (2014) [36] | 1993–1999 | HPFS study—males | 833 | NR | – | 146 | 17.50% | – |
CVD | Menzaghi (2014) [36] | 1976–1990 | NMS study—females | 902 | NR | – | 144 | 16.00% | – |
CVD | Salinero-Fort (2016) [35] | 2007–08 to 2012 | T2DM adults | 2442 | 203 | 8.30% | 96 | 3.90% | 47.30% |
CVD | Salinero-Fort (2016) [35] | 2007–08 to 2012 | T2DM adults + kidney disease | 965 | 221 | 22.90% | 124 | 12.80% | 56.10% |
CVD | Shestakova (2016) [29] | 2015 | T2DM adults | 3,060,516 | 66,093 | 2.20% | 30,560 | 1.00% | 46.20% |
All CVD death | Patients with T2DM | 3,208,557 | 86,557a | 42.3%a | 36,576a | 9.9%a | 50.3%a | ||
CAD | Cardoso (2008) [31] | 1994–1996 to 2001 | T2DM adults | 471 | 121 | 25.70% | 30 | 6.40% | 24.80% |
CAD | Carnethon (2010) [32] | 1989–1993 to 2005 | T2DM only | 659 | 468 | 71.00% | 132 | 20.00% | 28.20% |
CAD | Carnethon (2010) [32] | 1989–1993 to 2005 | CVD only | 868 | 620 | 71.40% | 213 | 24.50% | 34.40% |
CAD | Carnethon (2010) [32] | 1989–1993 to 2005 | T2DM + CVD | 260 | 219 | 84.20% | 111 | 42.70% | 50.70% |
CAD | Carnethon (2010) [32] | 1989–1993 to 2005 | No T2DM or CVD | 3997 | 2095 | 52.40% | 425 | 10.60% | 20.30% |
CAD | Jackson (2012) [97] | 2001–2007 | Male diabetics | 116,145 | 22,033 | 19.00% | 6000 | 5.20% | 27.20% |
CAD | Jackson (2012) [97] | 2001–2007 | Male non-diabetics | 2,433,748 | 36,801 | 1.50% | |||
CAD | Jackson (2012) [97] | 2001–2007 | Female diabetics | 100,507 | 20,571 | 20.50% | 4554 | 4.50% | 22.10% |
CAD | Jackson (2012) [97] | 2001–2007 | Female non-diabetics | 2,630,482 | 32,449 | 1.20% | |||
All CAD death | Patients with T2DM | 218,462a | 42,944a | 24.9%a | 10,695a | 6.3%a | 29.7%a | ||
CHF | Mazza (2007) [104] | 1983–1985 to 1997 | Male diabetics | 202 | – | – | 22 | 10.90% | – |
CHF | Mazza (2007) [104] | 1983–1985 to 1997 | Female diabetics | 379 | – | – | 29 | 7.70% | – |
CHF | Mazza (2007) [104] | 1983–1985 to 1997 | All | 581 | 369 | 63.50% | – | – | 13.80% |
CHF | Shestakova (2016) [29] | 2015 | T2DM adults | 3,060,516 | 66,093 | 2.20% | 18,963 | 0.60% | 28.70% |
All CHF deaths | Patients with T2DM | 3,061,097a | 66,093a | 2.2%a | 1,9104a | 6.1%a | 28.7%a | ||
MI | Shestakova (2016) [29] | 2015 | T2DM adults | 3,060,516 | 66,093 | 2.20% | 3393 | 0.10% | 5.10% |
SCD | Kucharska-Newton (2010) [99] | 1987–89 to 2001 | T2DM adults | 1550 | NR | – | 69 | 4.50% | – |
SCD | Kucharska-Newton (2010) [99] | 1987–89 to 2001 | No T2DM | 12,428 | NR | – | 140 | 1.10% | – |
Stroke | Jackson (2012) [97] | 2001–2007 | Male diabetics | 116,145 | 22,033 | 19.00% | 1942 | 1.70% | 8.80% |
Stroke | Jackson (2012) [97] | 2001–2007 | Male non-diabetics | 2,433,748 | 13,191 | 0.50% | |||
Stroke | Jackson (2012) [97] | 2001–2007 | Female diabetics | 100,507 | 20,571 | 20.50% | 2436 | 2.40% | 11.80% |
Stroke | Jackson (2012) [97] | 2001–2007 | Female non-diabetics | 2,630,482 | 23,632 | 0.90% | |||
Stroke | Shestakova (2016) [29] | 2015 | T2DM adults | 3,060,516 | 66,093 | 2.20% | 8204 | 0.30% | 12.40% |
All CBV deaths | Patients with T2DM | 327,168a | 108,697a | 3.30% | 12,582a | 1.50% | 11.0%a |